bisacodyl
Selected indexed studies
- Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation. (Neurogastroenterol Motil, 2021) [PMID:33751780]
- [Bisacodyl as laxative in Belgian pharmacy]. (J Pharm Belg, 2016) [PMID:30281225]
- Bisacodyl Limits Chikungunya Virus Replication In Vitro and Is Broadly Antiviral. (Antimicrob Agents Chemother, 2022) [PMID:35652314]
_Worker-drafted node — pending editorial review._
Connections
bisacodyl is a side effect of
Sources
- Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation. (2021) pubmed
- [Bisacodyl as laxative in Belgian pharmacy]. (2016) pubmed
- Bisacodyl Limits Chikungunya Virus Replication In Vitro and Is Broadly Antiviral. (2022) pubmed
- Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review. (2021) pubmed
- Bisacodyl Suppresses TGF-α-Induced MUC5AC Production in NCI-H292 Cells. (2021) pubmed
- Low-volume polyethylene glycol and bisacodyl for bowel preparation prior to colonoscopy: a meta-analysis. (2013) pubmed
- Combined MRI, high-resolution manometry and a randomised trial of bisacodyl versus hyoscine show the significance of an enlarged colon in constipation: the RECLAIM study. (2024) pubmed
- [Bisacodyl suppositories]. (1970) pubmed
- Characterization of the colonic response to bisacodyl in children with treatment-refractory constipation. (2020) pubmed
- Long-term Use of Bisacodyl in Pediatric Functional Constipation Refractory to Conventional Therapy. (2020) pubmed